Ver mas grande
IRF9 antibody
FT-FNab04397
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IF, IP |
| Target | IRF9 |
| Research Area | Epigenetics, Signal Transduction, Metabolism, Cancer, Immunology |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:1000 |
| Type Clonality | polyclonal |
| Immunogen | interferon regulatory factor 9 |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Interferon regulatory factor 9 (IRF-9)|IFN-alpha-responsive transcription factor subunit|ISGF3 p48 subunit|Interferon-stimulated gene factor 3 gamma (ISGF-3 gamma)|Transcriptional regulator ISGF3 subunit gamma|IRF9|ISGF3G |
| Host | Rabbit |
| UniProt ID | Q00978 |
| Gene ID | 10379 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 48kd |
| Background | Transcription factor that mediates signaling by type I IFNs(IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases(TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G asso |
Más información
IRF9 antibody